IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9737534 B1

PDFFull Text
Date of Patent:
Aug. 22, 2017

Filed:

Aug. 31, 2015

Oxazoline and isoxazoline derivatives as crac modulators

Applicant:

Lupin Limited, Mumbai, Maharashtra, IN;

Inventors:

Nageswara Rao Irlapati, Maharashtra, IN;

Gokul Keruji Deshmukh, Maharashtra, IN;

Vijay Pandurang Karche, Maharashtra, IN;

Santosh Madhukar Jachak, Maharashtra, IN;

Neelima Sinha, Maharashtra, IN;

Venkata P. Palle, Maharashtra, IN;

Rajender Kumar Kamboj, Maharashtra, IN;

Assignee:

LUPIN LIMITED, Mumbai, IN;

Attorney:

Merchant & Gould P.C.

Primary Examiner:

Irina Neagu

Int. Cl.
CPC ...
C07D 271/113 (2006.01); A61K 31/4245 (2006.01); A61P 19/02 (2006.01); A61K 31/497 (2006.01); C07D 261/12 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/422 (2006.01); A61K 31/423 (2006.01); A61K 31/433 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 31/497 (2013.01); A61K 31/42 (2013.01); A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/423 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); C07D 261/12 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01);
Abstract

The present invention relates to compounds of Formula (I), along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).

Find Patent Forward Citations

Loading…